Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 127,683 |
|
|||||
| News | - | ||||||
| Day High | 5.753 | Low High |
|||||
| Day Low | 4.40 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Conduit Pharmaceuticals Inc | CDT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.92 | 19.66% | 5.60 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.53 | 4.40 | 5.753 | 5.51 | 4.68 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,134 | 127,683 | $ 5.01 | $ 639,908 | - | 0.95 - 12.89 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:52:30 | 15 | $ 5.11 | USD |
Conduit Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 252.75M | 15.00M | - | 0 | 399k | 0.03 | 633.46 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Conduit Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.80 | 6.50 | 1.71 | 4.56 | 548,949 | 3.80 | 211.11% |
| 1 Month | 1.47 | 6.50 | 1.06 | 3.80 | 192,025 | 4.13 | 280.95% |
| 3 Months | 12.60 | 12.89 | 0.95 | 2.38 | 559,892 | -7.00 | -55.56% |
| 6 Months | 12.60 | 12.89 | 0.95 | 2.38 | 559,892 | -7.00 | -55.56% |
| 1 Year | 12.60 | 12.89 | 0.95 | 2.38 | 559,892 | -7.00 | -55.56% |
| 3 Years | 12.60 | 12.89 | 0.95 | 2.38 | 559,892 | -7.00 | -55.56% |
| 5 Years | 12.60 | 12.89 | 0.95 | 2.38 | 559,892 | -7.00 | -55.56% |
Conduit Pharmaceuticals Description
| Conduit Pharmaceuticals, Inc. is a disease agnostic life science company. The Company is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. The Company¿s licensed clinical assets are focused on idiopathic male infertility and autoimmune diseases or immunodeficient conditions like uveitis, preterm labor, renal transplant rejection and Hashimoto¿s Thyroiditis. The Company¿s asset pipeline includes AZD1656 (a Glucokinase Activator), and AZD5904 (a Myeloperoxidase Inhibitor). AZD1656 is a glucokinase activator used in diabetes mellitus. It is used as a treatment option for Hashimoto¿s Thyroiditis (HT) and Graves¿ disease, including investigating any negative side effects of the use of AZD1656 as compared with treatment options for Hashimoto¿s Thyroiditis and Graves¿ disease. AZD5904 includes a potent, irreversible inhibitor of human myeloperoxidase (MPO), that has the potential to treat Idiopathic Male Infertility (IMI). |
